THESEUS PHARMACEUTICALS, INC. Operating Expenses
THESEUS PHARMACEUTICALS, INC. reported Operating Expenses of $16.40 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2023-09-30 was $16.40M, a 2.85% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2023-06-30 was $17.59M, a 45.59% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2023-03-31 was $17.05M, a 61.22% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2022-12-31 was $15.48M, a 78.76% increase year-over-year.
- THESEUS PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $54.09M, a 97.86% increase from fiscal 2021.
- THESEUS PHARMACEUTICALS, INC. operating expenses for fiscal 2021 was $27.34M, a 299.88% increase from fiscal 2020.
- THESEUS PHARMACEUTICALS, INC. operating expenses for fiscal 2020 was $6.84M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-09-30 | $16.40M 10-Q · filed 2023-11-17 | $33.99M derived: sum of 2 quarters · filed 2023-11-17 | $51.05M 10-Q · filed 2023-11-17 | $66.52M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $17.59M 10-Q · filed 2023-08-10 | $34.64M 10-Q · filed 2023-08-10 | $50.12M derived: sum of 3 quarters · filed 2023-08-10 | $66.07M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $17.05M 10-Q · filed 2023-05-11 | $32.53M derived: sum of 2 quarters · filed 2023-05-11 | $48.48M derived: sum of 3 quarters · filed 2023-11-17 | $60.56M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-12-31 | $15.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $31.43M derived: sum of 2 quarters · filed 2023-11-17 | $43.51M derived: sum of 3 quarters · filed 2023-11-17 | $54.09M 10-K · filed 2023-03-09 |
| 2022-09-30 | $15.95M 10-Q · filed 2023-11-17 | $28.03M derived: sum of 2 quarters · filed 2023-11-17 | $38.61M 10-Q · filed 2023-11-17 | $47.27M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-06-30 | $12.08M 10-Q · filed 2023-08-10 | $22.66M 10-Q · filed 2023-08-10 | $31.32M derived: sum of 3 quarters · filed 2023-08-10 | $38.69M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $10.58M 10-Q · filed 2023-05-11 | $19.24M derived: sum of 2 quarters · filed 2023-05-11 | $26.61M derived: sum of 3 quarters · filed 2023-05-11 | $33.43M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $16.03M derived: sum of 2 quarters · filed 2023-03-09 | $22.85M derived: sum of 3 quarters · filed 2023-03-09 | $27.34M 10-K · filed 2023-03-09 |
| 2021-09-30 | $7.37M 10-Q · filed 2022-11-03 | $14.19M derived: sum of 2 quarters · filed 2022-11-03 | $18.68M 10-Q · filed 2022-11-03 | $21.57M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $6.81M 10-Q · filed 2022-08-11 | $11.30M 10-Q · filed 2022-08-11 | $14.19M derived: sum of 3 quarters · filed 2022-08-11 | $15.62M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $4.49M 10-Q · filed 2022-05-12 | $7.38M derived: sum of 2 quarters · filed 2022-05-12 | $8.81M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $4.32M derived: sum of 2 quarters · filed 2022-03-10 | $6.84M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $1.43M 10-Q · filed 2021-11-15 | $3.95M 10-Q · filed 2021-11-15 |